Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review
Open Access
- 29 September 2021
- journal article
- review article
- Published by Wiley in Veterinary Surgery
- Vol. 51 (1) , 23-33
Abstract
The development of postattenuation neurologic signs (PANS) is a poorly understood and potentially devastating complication after surgical attenuation of congenital portosystemic shunts in dogs. Postattenuation neurologic signs include seizures but also more subtle neurologic signs such as depression, behavioral changes, tremors, and twitching. They most commonly occur within 7 days postoperatively and are typically unrelated to hyperammonemia, hypoglycemia, or electrolyte disturbances. This narrative review summarizes the findings of 50 publications from 1988‐2020 that report occurrence ofPANS. While most published reports included only dogs affected by postattenuation seizures (PAS), others included dogs with any form ofPANS. Overall,PANS(includingPAS) affected 1.6%‐27.3% of dogs, whereas incidence ofPASranged from 0%‐18.2%. The etiology ofPANSremains unknown; however, several theories have been proposed. Risk factors include preoperative hepatic encephalopathy, increasing age, and possibly certain breeds and extrahepatic shunt morphology. There is increasing evidence that prophylactic antiepileptic drugs do not preventPANS. Treatment is centered around controlling neurologic signs with antiepileptic drugs and providing supportive intensive care. The 30‐day survival rate in studies that included a minimum of four dogs affected byPANSwas 0%‐100% (median, 50.0%) and 0%‐75.0% (median, 37.5%) for those withPAS. Mortality associated withPANSwas typically related to occurrence of generalized seizure activity. Prognostic factors positively associated with short‐term survival included having a history of preoperative seizures and development of focal seizures only. If affected dogs survived to discharge, survival for several years was possible, and the majority of neurologic signs manifested as part of the phenomenon ofPANSappeared to resolve.Keywords
This publication has 59 references indexed in Scilit:
- Incidence of Postoperative Seizures with and without Levetiracetam Pretreatment in Dogs Undergoing Portosystemic Shunt AttenuationJournal of Veterinary Internal Medicine, 2011
- Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbitalJournal of Veterinary Emergency and Critical Care, 2010
- Liver Size, Bodyweight, and Tolerance to Acute Complete Occlusion of Congenital Extrahepatic Portosystemic Shunts in DogsVeterinary Surgery, 2008
- Use of transcolonic portal scintigraphy to evaluate efficacy of cellophane banding of congenital extrahepatic portosystemic shunts in 16 dogsAustralian Veterinary Journal, 2008
- Clinical outcome of congenital extrahepatic portosystemic shunt attenuation in dogs aged five years and older: 17 cases (1992–2005)Journal of the American Veterinary Medical Association, 2008
- Surgical Management of Left‐Divisional Intrahepatic Portosystemic Shunts: Outcome After Partial Ligation of, or Ameroid Ring Constrictor Placement on, the Left Hepatic Vein in Twenty‐Eight Dogs (1995–2005)Veterinary Surgery, 2007
- Evaluation of cellophane banding with and without intraoperative attenuation for treatment of congenital extrahepatic portosystemic shunts in dogsJournal of the American Veterinary Medical Association, 2006
- Re‐Evaluation of a Portocaval Venograft Without an Ameroid Constrictor as a Method for Controlling Portal Hypertension After Occlusion of Intrahepatic Portocaval Shunts in DogsVeterinary Surgery, 2004
- Iron Status and Erythrocyte Volume in Dogs With Congenital Portosystemic Vascular AnomaliesJournal of Veterinary Internal Medicine, 1997
- Long‐Term Results of Complete and Partial Ligation of Congenital Portosystemic Shunts in DogsVeterinary Surgery, 1995